ATE395325T1 - Neues kristallines stilben-derivat und verfahren zu dessen herstellung - Google Patents

Neues kristallines stilben-derivat und verfahren zu dessen herstellung

Info

Publication number
ATE395325T1
ATE395325T1 AT01912367T AT01912367T ATE395325T1 AT E395325 T1 ATE395325 T1 AT E395325T1 AT 01912367 T AT01912367 T AT 01912367T AT 01912367 T AT01912367 T AT 01912367T AT E395325 T1 ATE395325 T1 AT E395325T1
Authority
AT
Austria
Prior art keywords
crystal
production
new crystalline
type
water
Prior art date
Application number
AT01912367T
Other languages
English (en)
Inventor
Shinichiro Takahashi
Yoko Sugawara
Hiroyuki Matsueda
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE395325T1 publication Critical patent/ATE395325T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01912367T 2000-03-17 2001-03-14 Neues kristallines stilben-derivat und verfahren zu dessen herstellung ATE395325T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000076887 2000-03-17

Publications (1)

Publication Number Publication Date
ATE395325T1 true ATE395325T1 (de) 2008-05-15

Family

ID=18594552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01912367T ATE395325T1 (de) 2000-03-17 2001-03-14 Neues kristallines stilben-derivat und verfahren zu dessen herstellung

Country Status (13)

Country Link
US (1) US6784315B2 (de)
EP (1) EP1264821B1 (de)
JP (1) JP4826051B2 (de)
CN (1) CN1221527C (de)
AT (1) ATE395325T1 (de)
AU (1) AU2001241140A1 (de)
DE (1) DE60133995D1 (de)
DK (1) DK1264821T3 (de)
ES (1) ES2306705T3 (de)
PT (1) PT1264821E (de)
SI (1) SI1264821T1 (de)
TW (1) TWI291459B (de)
WO (1) WO2001068587A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007254292A (ja) * 2006-03-20 2007-10-04 Nippon Polyurethane Ind Co Ltd ジフェニルスルホンジイソシアネートの製造方法
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP3184095A1 (de) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Verabreichungseinheiten die ein polymorph 1 von 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide beinhalten

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
JP4826051B2 (ja) 2011-11-30
US6784315B2 (en) 2004-08-31
US20030065035A1 (en) 2003-04-03
TWI291459B (en) 2007-12-21
ES2306705T3 (es) 2008-11-16
AU2001241140A1 (en) 2001-09-24
EP1264821A4 (de) 2005-06-08
DE60133995D1 (de) 2008-06-26
PT1264821E (pt) 2008-08-12
CN1418186A (zh) 2003-05-14
SI1264821T1 (sl) 2008-10-31
EP1264821A1 (de) 2002-12-11
CN1221527C (zh) 2005-10-05
WO2001068587A1 (en) 2001-09-20
EP1264821B1 (de) 2008-05-14
DK1264821T3 (da) 2008-09-08

Similar Documents

Publication Publication Date Title
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
HUP0401982A2 (hu) Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
WO2004056786A3 (en) Pyrimidine derivates for the treatment of abnormal cell growth
WO2003064404A1 (en) 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AR034259A1 (es) Polimorfos de un analogo de epotilona, procesos para prepararlos y las composiciones farmaceuticas que los contienen
NO20045103L (no) Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse
CA2394120A1 (en) Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
WO2003097656A3 (en) Novel substituted sulfamate anticonvulsant derivatives
PL315035A1 (en) Cyclic amide derivatives as antagonistic substances in respect to neurokinin a
AU663200B2 (en) New 3-(hydroxybenzylidenyl)-indolin-2-ones, processes for their preparation and pharmaceutical compositions containing them
CA2373117A1 (en) 13-methyl-erythromycin derivatives
WO2006046031A8 (en) Pharmaceutical compounds
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
NO20052683L (no) Nye pyridopyrimidinonforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
HUT69391A (en) Pregnanes and androstanes substituted by 2-beta-morpholine derivatives and pharmaceutical compositions containing the same and process for their production
NO20016389L (no) Fremgangsmåte for fremstilling av substituerte cyklopentanderivater og nye krystallinske strukturer derav
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
CA2060616A1 (en) Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers
DE60133995D1 (de) Neues kristallines stilben-derivat und verfahren zu dessen herstellung
WO2004091627A3 (en) Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs
EP1390343A4 (de) Neue retinoidderivate und verfahren zur herstellung dieser verbindungen, sowie eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
WO2000064902A3 (en) Process for the preparation of calanolide precursors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1264821

Country of ref document: EP